Home | Video pages | Webcast | Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies

Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies

Access paper

https://www.youtube.com/watch?v=OYv5O4yBRm8 copy

Other e-seminars from this series

E-seminar

SGLT2 inhibition for patients with ADPKD – closing the evidence

ERA Journal Club

Webcast

Potential and pitfalls of measuring circulating anti-nephrin autoantibodies in glomerular diseases

ERA Journal Club

Webcast

Disease-modifying anti-nephropathic drugs (DMANDs) – A definition proposed by the IWG of ERA

ERA Journal Club

Webcast

Digital physical activity intervention via the Kidney BEAM platform in patients with polycystic kidney disease

ERA Journal Club

Webcast

Aldosterone synthase inhibitors in CKD (and EASi-KIDNEY’s outline design)

ERA Journal Club

Webcast

Epidemiological and clinicopathological characteristics of vascular-limited renal AL amyloidosis

ERA Journal Club

Webcast

Kidney Transplantation in Patients with Polycystic Kidney Disease

ERA Journal Club

Webcast

Post-transplant renal anaemia: a call to action from a national study in routine clinical practice

ERA Journal Club

Webcast

Low dialysate sodium and 48-h ambulatory blood pressure in patients with intradialytic hypertension

ERA Journal Club

Webcast

Using Artificial Intelligence to Predict Mortality in AKI Patients: A systematic review/Meta-Analysis

ERA Journal Club

Webcast

Clinical impact of the Kidney Failure Risk Equation for vascular access planning

ERA Journal Club

Webcast

Patient dynamics, suspensions, transplantation and deaths in the Australian kidney transplant waitlist

ERA Journal Club

Join the ERA Working Groups or renew your interest

Discover our Members’ stories

Enjoy the webcasts of ERA25

ERA fellowship applications are now open

Access ERA e-learning

Try the 'deaf' dumplings

Webcast available!

Webcast available!

Suggestions

Transient acute kidney injury after chimeric antigen receptor T-cell therapy in patients with hematological malignancies

Access paper

Other e-seminars from this series

SGLT2 inhibition for patients with ADPKD – closing the evidence

Potential and pitfalls of measuring circulating anti-nephrin autoantibodies in glomerular diseases

Disease-modifying anti-nephropathic drugs (DMANDs) – A definition proposed by the IWG of ERA

Digital physical activity intervention via the Kidney BEAM platform in patients with polycystic kidney disease

Aldosterone synthase inhibitors in CKD (and EASi-KIDNEY’s outline design)

Epidemiological and clinicopathological characteristics of vascular-limited renal AL amyloidosis

Kidney Transplantation in Patients with Polycystic Kidney Disease

Post-transplant renal anaemia: a call to action from a national study in routine clinical practice

Low dialysate sodium and 48-h ambulatory blood pressure in patients with intradialytic hypertension

Using Artificial Intelligence to Predict Mortality in AKI Patients: A systematic review/Meta-Analysis

Clinical impact of the Kidney Failure Risk Equation for vascular access planning

Patient dynamics, suspensions, transplantation and deaths in the Australian kidney transplant waitlist